Maraviroc Observational Study: The Impact of Expanded Resistance Testing and Clinical Considerations for Antiretroviral Regimen Selection in Treatment-Experienced Patients

Maraviroc (MVC) use has trailed that of other post-2006 antiretroviral therapy (ART) options for treatment-experienced patients. We explored the impact of free tropism testing on MVC utilization in our cohort and explored barriers to MVC utilization. The Maraviroc Outcomes Study (MOS) is an investig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Willig, James H., Wilkins, Sara-Anne, Tamhane, Ashutosh, Nevin, Christa R., Mugavero, Michael J., Raper, James L., Napolitano, Laura A., Saag, Michael S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2013
Materias:
Outcomes Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608020/
https://ncbi.nlm.nih.gov/pubmed/22881368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2012.0157
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares